154 related articles for article (PubMed ID: 11027313)
1. Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-kappa B and the glucocorticoid receptor.
Doucas V; Shi Y; Miyamoto S; West A; Verma I; Evans RM
Proc Natl Acad Sci U S A; 2000 Oct; 97(22):11893-8. PubMed ID: 11027313
[TBL] [Abstract][Full Text] [Related]
2. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids.
Caldenhoven E; Liden J; Wissink S; Van de Stolpe A; Raaijmakers J; Koenderman L; Okret S; Gustafsson JA; Van der Saag PT
Mol Endocrinol; 1995 Apr; 9(4):401-12. PubMed ID: 7659084
[TBL] [Abstract][Full Text] [Related]
3. CBP (CREB binding protein) integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism.
McKay LI; Cidlowski JA
Mol Endocrinol; 2000 Aug; 14(8):1222-34. PubMed ID: 10935546
[TBL] [Abstract][Full Text] [Related]
4. Requirement of thyrotropin-dependent complex formation of protein kinase A catalytic subunit with inhibitor of {kappa}B proteins for activation of p65 nuclear factor-{kappa}B by tumor necrosis factor-{alpha}.
Cao X; Kambe F; Seo H
Endocrinology; 2005 Apr; 146(4):1999-2005. PubMed ID: 15637292
[TBL] [Abstract][Full Text] [Related]
5. TNF-alpha-induced NF-kappaB/RelA Ser(276) phosphorylation and enhanceosome formation is mediated by an ROS-dependent PKAc pathway.
Jamaluddin M; Wang S; Boldogh I; Tian B; Brasier AR
Cell Signal; 2007 Jul; 19(7):1419-33. PubMed ID: 17317104
[TBL] [Abstract][Full Text] [Related]
6. Decrease in RelA phosphorylation by inhibiting protein kinase A induces cell death in NF-kappaB-expressing and drug-resistant tumor cells.
Manna SK; Gangadharan C
Mol Immunol; 2009 Apr; 46(7):1340-50. PubMed ID: 19128834
[TBL] [Abstract][Full Text] [Related]
7. Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism.
McKay LI; Cidlowski JA
Mol Endocrinol; 1998 Jan; 12(1):45-56. PubMed ID: 9440809
[TBL] [Abstract][Full Text] [Related]
8. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering.
Ratman D; Vanden Berghe W; Dejager L; Libert C; Tavernier J; Beck IM; De Bosscher K
Mol Cell Endocrinol; 2013 Nov; 380(1-2):41-54. PubMed ID: 23267834
[TBL] [Abstract][Full Text] [Related]
9. A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of RelA transactivation.
Liden J; Delaunay F; Rafter I; Gustafsson J; Okret S
J Biol Chem; 1997 Aug; 272(34):21467-72. PubMed ID: 9261164
[TBL] [Abstract][Full Text] [Related]
10. Impact of Chronic Stress on the Spatial Learning and GR-PKAc-NF-κB Signaling in the Hippocampus and Cortex in Rats Following Cholinergic Depletion.
Lee SY; Cho WH; Lee YS; Han JS
Mol Neurobiol; 2018 May; 55(5):3976-3989. PubMed ID: 28551869
[TBL] [Abstract][Full Text] [Related]
11. Increased interactions between PKA and NF-κB signaling in the hippocampus following loss of cholinergic input.
Lim CS; Hwang YK; Kim D; Cho SH; Bañuelos C; Bizon JL; Han JS
Neuroscience; 2011 Sep; 192():485-93. PubMed ID: 21723926
[TBL] [Abstract][Full Text] [Related]
12. Distinct domains of the RelA NF-kappaB subunit are required for negative cross-talk and direct interaction with the glucocorticoid receptor.
Wissink S; van Heerde EC; Schmitz ML; Kalkhoven E; van der Burg B; Baeuerle PA; van der Saag PT
J Biol Chem; 1997 Aug; 272(35):22278-84. PubMed ID: 9268377
[TBL] [Abstract][Full Text] [Related]
13. Repression of p65 transcriptional activation by the glucocorticoid receptor in the absence of receptor-coactivator interactions.
Wu J; Li Y; Dietz J; Lala DS
Mol Endocrinol; 2004 Jan; 18(1):53-62. PubMed ID: 14551261
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of NF-kappa B binding correlates with increased nuclear glucocorticoid receptor levels in acute alcohol-treated human monocytes.
Mandrekar P; Bellerose G; Szabo G
Alcohol Clin Exp Res; 2002 Dec; 26(12):1872-9. PubMed ID: 12500112
[TBL] [Abstract][Full Text] [Related]
15. Interaction of mitochondrial thioredoxin with glucocorticoid receptor and NF-kappaB modulates glucocorticoid receptor and NF-kappaB signalling in HEK-293 cells.
Psarra AM; Hermann S; Panayotou G; Spyrou G
Biochem J; 2009 Aug; 422(3):521-31. PubMed ID: 19570036
[TBL] [Abstract][Full Text] [Related]
16. Identification of endogenous glucocorticoid repressed genes differentially regulated by a glucocorticoid receptor mutant able to separate between nuclear factor-kappaB and activator protein-1 repression.
Bladh LG; Lidén J; Dahlman-Wright K; Reimers M; Nilsson S; Okret S
Mol Pharmacol; 2005 Mar; 67(3):815-26. PubMed ID: 15550679
[TBL] [Abstract][Full Text] [Related]
17. Cytosolic glucocorticoid receptor interaction with nuclear factor-kappa B proteins in rat liver cells.
Widén C; Gustafsson JA; Wikström AC
Biochem J; 2003 Jul; 373(Pt 1):211-20. PubMed ID: 12672265
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms for corticotropin-releasing hormone gene repression by glucocorticoid in BE(2)C neuronal cell line.
Yamamori E; Iwasaki Y; Taguchi T; Nishiyama M; Yoshida M; Asai M; Oiso Y; Itoi K; Kambayashi M; Hashimoto K
Mol Cell Endocrinol; 2007 Jan; 264(1-2):142-8. PubMed ID: 17169483
[TBL] [Abstract][Full Text] [Related]
19. Differential hormone-dependent transcriptional activation and -repression by naturally occurring human glucocorticoid receptor variants.
de Lange P; Koper JW; Huizenga NA; Brinkmann AO; de Jong FH; Karl M; Chrousos GP; Lamberts SW
Mol Endocrinol; 1997 Jul; 11(8):1156-64. PubMed ID: 9212062
[TBL] [Abstract][Full Text] [Related]
20. Competition between glucocorticoid receptor and NFkappaB for control of the human FasL promoter.
Novac N; Baus D; Dostert A; Heinzel T
FASEB J; 2006 Jun; 20(8):1074-81. PubMed ID: 16770006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
